Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$25.48 - $37.34 $249,882 - $366,193
-9,807 Closed
0 $0
Q2 2021

Aug 04, 2021

BUY
$32.46 - $43.42 $15,483 - $20,711
477 Added 5.11%
9,807 $343,000
Q1 2021

May 10, 2021

BUY
$38.94 - $50.85 $10,319 - $13,475
265 Added 2.92%
9,330 $380,000
Q4 2020

Feb 08, 2021

BUY
$37.65 - $63.77 $341,297 - $578,075
9,065 New
9,065 $393,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.